Antidepressant therapeutic strategies and health care utilization in patients with depression [0.03%]
抑郁症患者的抗抑郁药治疗方案与卫生服务利用率关系研究
Phuong Tran,Susan dosReis,Eberechukwu Onukwugha et al.
Phuong Tran et al.
Background: Individuals with depression who do not respond to initial antidepressant may switch to a different antidepressant, add a second antidepressant, or add an atypical antipsychotic. Previous studies comparing thes...
Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period [0.03%]
2010—2019年医疗保险D部分专科药物支出占总支出的集中度和份额分析
Shu Niu,Laura E Happe,Sumaya Abuloha et al.
Shu Niu et al.
Background: In 2021, Medicare Part D gross prescription drug spending amounted to $216 billion, a number that has more than doubled over the last 10 years. Spending in Medicare Part D is concentrated on a small number of ...
Impact of a human papillomavirus vaccination clinical program in a commercially insured population [0.03%]
人乳头瘤病毒疫苗临床项目对商保人群的影响
Karli Pelaccio,Millie Mo,Allison Olmsted et al.
Karli Pelaccio et al.
Background: Human papillomavirus (HPV) results in 37,000 new cancers each year. HPV-attributable cancers are preventable through vaccination with the completion of the HPV series encouraged by age 13 years. Public uptake ...
Fear of missing out: Drug availability in the United States vs Canada [0.03%]
美国与加拿大药物可及性的差异：不要错过救命药
Mina Tadrous,Clara Chen,Katherine Callaway Kim et al.
Mina Tadrous et al.
Background: Per capita spending on drugs in the United States is double that of Canada. One commonly debated point when comparing the 2 countries is whether this additional spending allows residents of the United States a...
Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United States [0.03%]
在美国接受伊沙佐米或达雷木单抗联合来那度胺和地塞米松治疗复发/难治性多发性骨髓瘤患者的医疗费用分析
Sikander Ailawadhi,Mu Cheng,Maral DerSarkissian et al.
Sikander Ailawadhi et al.
Background: Available treatments for relapsed/refractory multiple myeloma (RRMM) include multiclass triplet regimens such as lenalidomide and dexamethasone (Rd backbone) plus ixazomib (proteasome inhibitor [PI]; I) or dar...
Initiating continuous glucose monitoring is associated with improvements in glycemic control and reduced health care resource utilization for people with diabetes in a large US-insured population: A real-world evidence study [0.03%]
在美国一个大型保险人口中开始连续葡萄糖监测与糖尿病患者的血糖控制改善和降低医疗保健资源利用有关：一项现实世界证据研究
Gregory J Norman,Joaquim Fernandes,Poorva Nemlekar et al.
Gregory J Norman et al.
Objective: To examine the real-world impact of continuous glucose monitoring (CGM) use on glycemic management and health care resource utilization (HCRU) in people with diabetes in a large US-insured population. ...
Observational Study
Journal of managed care & specialty pharmacy. 2025 Jan;31(1):15-24. DOI:10.18553/jmcp.2024.24255 2025
It is time for a more nuanced discussion about pharmacy benefit managers [0.03%]
是时候进行更细致的药物福利管理公司讨论了
Susan A Cantrell
Susan A Cantrell
Stakeholder insights on cost, quality, and incorporating patient voice in managed care decisions on neovascular (wet) age-related macular degeneration: Findings from the AMCP Market Insights program [0.03%]
_managed care决策中关于年龄相关性黄斑变性的成本、质量及患者声音的各方观点：AMCP市场洞察项目的成果报告_
Bridget Flavin,Andrew Schimel,Zachary Contreras et al.
Bridget Flavin et al.
Wet age-related macular degeneration (AMD) is an acquired degeneration of the retina that can lead to central vision impairment. It is primarily treated with intravitreal injections of vascular endothelial growth factor inhibitors. Although...
Unlocking the potential of digital therapeutics: The need for consistent and granular inclusion in drug compendia for managed care [0.03%]
数字治疗的潜力：药物汇编中纳入经管护理的一致性和细化的需求分析
Ann Johnson,Rick Bartels,Joe Honcz et al.
Ann Johnson et al.
The field of digital therapeutics (DTx), software programs that prevent, manage, and treat medical conditions, continues to grow. DTx offers new treatment options and has the potential to close gaps in care caused by unmet patient needs, pr...
AMCP Partnership Forum: Patient input and payer decision-making [0.03%]
AMSUS会议演讲：从患者的角度思考支付方的决策制定过程
There has been growing consensus for the health care community to become more patient centered by considering patient needs, preferences, and values in decision-making. To advance partnership between payers and patient representatives to ga...